Cargando…
Sildenafil Can Affect Innate and Adaptive Immune System in Both Experimental Animals and Patients
Sildenafil, a type 5 phosphodiesterase inhibitor (PDE5-I), is primarily used for treating erectile dysfunction. Sildenafil inhibits the degradation of cyclic guanosine monophosphate (cGMP) by competing with cGMP for binding site of PDE5. cGMP is a secondary messenger activating protein kinases and a...
Autores principales: | Kniotek, Monika, Boguska, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337856/ https://www.ncbi.nlm.nih.gov/pubmed/28316997 http://dx.doi.org/10.1155/2017/4541958 |
Ejemplares similares
-
Sildenafil, a Phosphodiesterase Type 5 Inhibitor, Downregulates Osteopontin in Human Peripheral Blood Mononuclear Cells
por: Kaleta, Beata, et al.
Publicado: (2017) -
Sildenafil Citrate Influences Production of TNF-α in Healthy Men Lymphocytes
por: Zych, Michał, et al.
Publicado: (2019) -
Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity
por: von Roemeling, Christina A., et al.
Publicado: (2020) -
Decreased Production of TNF-α and IL-6 Inflammatory Cytokines in Non-Pregnant Idiopathic RPL Women Immunomodulatory Effect of Sildenafil Citrate on the Cellular Response of Idiopathic RPL Women
por: Kniotek, Monika, et al.
Publicado: (2021) -
Sildenafil Citrate Downregulates PDE5A mRNA Expression in Women with Recurrent Pregnancy Loss without Altering Angiogenic Factors—A Preliminary Study
por: Kniotek, Monika, et al.
Publicado: (2021)